lobbying_activities: 1261398

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1261398	794f0916-a7b8-4184-8b0f-54add4ed88ac	Q2	CAPITOL HILL CONSULTING GROUP	72053	PURDUE PHARMA LLP	2012	second_quarter	PHA	Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)	HOUSE OF REPRESENTATIVES,SENATE	32000		0	0	2012-07-12T17:44:17.667000-04:00